{'fraction_non_alphanumeric': 0.0542832909245123, 'fraction_numerical': 0.03477523324851569, 'mean_word_length': 5.079896907216495, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
IMPACT OF THYROID AUTOIMMUNITY ON ASSISTED REPRODUCTIVE TECHNOLOGY OUTCOMES AND OVARIAN RESERVE MARKERS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS.

BACKGROUND
Thyroid autoimmunity (TAI) has a high prevalence among women of reproductive age. Investigating its possible impact on ovarian function and fertility is thus of utmost relevance. The aim of this systematic review and meta-analysis was to elucidate the effect of TAI on both assisted reproductive technology (ART) outcomes and ovarian reserve.


METHODS
This systematic review and meta-analysis was restricted to two groups of research articles investigating the association between TAI and: 1) autologous ART outcomes (i.e., fertilization rate (FR), implantation rate (IR), clinical pregnancy rate (CPR), miscarriage rate (MR) and live birth rate (LBR)), 2) markers of ovarian reserve (i.e., anti-Müllerian hormone (AMH), basal follicle stimulating hormone (FSH), antral follicle count (AFC) and number of oocytes retrieved (NOR)). Studies including women affected by overt hypo/hyperthyroidism were excluded. Relevant studies were identified by a systematic search in PubMed, MEDLINE, ClinicalTrials.gov, Embase and Scopus, from database inception to May 1st, 2022.


RESULTS
From a total of 432 identified publications, 22 studies were included in Group 1 and 26 studies in Group 2. The presence of TAI was associated with a higher risk of miscarriage (7606 participants, odds ratio (OR) 1.52, 95% confidence interval (CI) [1.14, 2.01], p=0.004, I2=53%), lower chance of embryo implantation (7118 participants, OR 0.72, 95% CI [0.59, 0.88], p=0.001, I2=36%) and live birth (11417 participants, OR 0.73, 95% CI [0.56-0.94], p=0.02, I2=71%). These associations were no longer observed in a subgroup analysis of patients who exclusively underwent intracytoplasmic sperm injection (ICSI). The FR and CPR as well as the mean values of surrogate markers of oocyte quantity appeared not to be affected by TAI.


CONCLUSIONS
This data synthesis suggests a higher risk of adverse ART outcomes in women with positive TAI. However, the reliability of these findings is hampered by the relatively low quality of the evidence and significant heterogeneity in many of the meta-analyses. The possible protective effect of ICSI is promising but should be confirmed in controlled prospective clinical trials.